Safety of AI-Powered Virtual Assistant in Outpatient Management of Heart Failure
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: HF-guided VA, Standard-of-care.
- Who it may be relevant to
- Registry conditions: Heart Failure. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United Kingdom
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Safety of AI-Powered Virtual Assistant in Outpatient Management of Heart Failure: A Randomized Controlled Pilot Study: ASSIST-HF SIRIO
Overview
The aim of this pilot randomized study is to examine whether integrating the SIRIO-HF virtual assistant (VA) into the outpatient management of participants recently discharged from hospital with a new diagnosis of heart failure (HF), may reduce the need for regular medical assessment and the healthcare burden, reduce variability in healthcare, and meet with participant satisfaction, without compromising participant safety and overall care quality.
Interventions
- Other HF-guided VA
VA guided recommendation - Other Standard-of-care
Standard-of-care
Primary outcome measures
- Acceptability of the intervention to users (participants) [Time frame: 12 weeks]
Eligibility criteria
Inclusion criteria
- Age ≥ 18 years
- Newly diagnosed HF with New York Heart Association class II-III symptoms at discharge
Exclusion criteria
- Known prior history of HF
- Severe comorbidities that could affect protocol adherence, in the opinion of the investigator
- Alternative diagnosis for symptoms such as chronic obstructive pulmonary disease
- Dementia or other cognitive impairment
- Currently involved in another interventional clinical trial
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Other
Study locations
United Kingdom · 1 center
- East and North Hertfordshire NHS Trust — Stevenage
Identifiers
NCT: NCT06400927 · RD2024-10